How would you boost a high-risk prostate cancer patient who received standard fractionation treatment and is not able to get LDR boost given COVID-19?  

Would you use SBRT, hypofractionated or standard fractionated boost?



Answer from: Radiation Oncologist at Academic Institution

Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at CoxHealth Radiation Oncology
As long as the patient is on androgen deprivation,...
Sign in or Register to read more

Answer from: Radiation Oncologist at Community Practice